Immediate Impact

1 from Science/Nature 57 standout
Sub-graph 1 of 24

Citing Papers

PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
2024 Standout
2 intermediate papers

Works of C. Stoffregen being referenced

Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation
2013
A double‐blind, randomized, placebo‐controlled, phase 2 study of maintenance enzastaurin with 5‐fluorouracil/leucovorin plus bevacizumab after first‐line therapy for metastatic colorectal cancer
2011

Author Peers

Author Last Decade Papers Cites
C. Stoffregen 262 238 176 199 41 666
Yuanzhong Yang 320 106 147 166 48 707
Sérgio D. Simon 485 168 135 149 46 737
Norma Alonzo Palma 312 240 333 218 28 720
Nimira Alimohamed 272 254 316 127 65 655
Ichiro Yamasaki 112 334 149 191 46 731
Ramón Palmero 371 317 60 155 48 618
T. Geldart 288 177 205 202 39 633
Eva Szentgyörgyi 341 141 174 285 28 675
Sanghui Park 256 129 216 190 61 774
Mélanie Claps 213 366 250 213 54 660

All Works

Loading papers...

Rankless by CCL
2026